MedPath

The Heart Health After Cardiac Treatment Study

Not Applicable
Recruiting
Conditions
Cardiac Rehabilitation
Registration Number
NCT07158515
Lead Sponsor
University of California, San Francisco
Brief Summary

The goal of this study is to determine whether participation in a tailored cardiac rehabilitation program delivered in a safety net setting, compared to usual care referral to an outside cardiac rehabilitation program, results in greater participation in cardiac rehabilitation.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  1. Age 18+

  2. Referred for cardiac rehabilitation for a covered indication:

    1. Acute myocardial infarction
    2. Percutaneous coronary intervention
    3. Coronary artery bypass surgery
    4. Heart valve repair or replacement
    5. Heart transplant
    6. Chronic stable angina
    7. Chronic systolic heart failure (EF <=35%)
  3. Able to communicate in English, Spanish, or Cantonese

  4. Able to consent for self

Exclusion Criteria
  1. Currently enrolled in hospice.
  2. Provider says patient may not be approached for participation in this study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Participation in at least 1 session of cardiac rehabilitation12 months

In each arm, we will calculate the proportion of participants who attended at least 1 cardiac rehabilitation session.

Secondary Outcome Measures
NameTimeMethod
Completion of cardiac rehabilitation12 months

In each arm, we will calculate the proportion of participants who attend at least 2/3 of expected sessions of cardiac rehabilitation (24 sessions in the active comparator arm and 8 sessions in the experimental arm)

Change in six-minute walk distance3 months

Change in distance walked in 6 minutes, following a standard protocol, from baseline to 3 months.

Change in quality of life3 months

Change in PROMIS Global Health physical and mental subscores between baseline and 3 months.

Trial Locations

Locations (1)

Zuckerberg San Francisco General Hospital

πŸ‡ΊπŸ‡Έ

San Francisco, California, United States

Zuckerberg San Francisco General Hospital
πŸ‡ΊπŸ‡ΈSan Francisco, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.